Cable Viewer

Currently released so far... 12576 / 251,287

### Browse latest releases

2010/11 2010/12 2011/01 2011/02 2011/03 2011/04 2011/05
2010/11/28 2010/11/29 2010/11/30
2010/12/01 2010/12/02 2010/12/03 2010/12/04 2010/12/05 2010/12/06 2010/12/07 2010/12/08 2010/12/09 2010/12/10 2010/12/11 2010/12/12 2010/12/13 2010/12/14 2010/12/15 2010/12/16 2010/12/17 2010/12/18 2010/12/19 2010/12/20 2010/12/21 2010/12/22 2010/12/23 2010/12/24 2010/12/25 2010/12/26 2010/12/27 2010/12/28 2010/12/29 2010/12/30
2011/01/01 2011/01/02 2011/01/04 2011/01/05 2011/01/07 2011/01/09 2011/01/10 2011/01/11 2011/01/12 2011/01/13 2011/01/14 2011/01/15 2011/01/16 2011/01/17 2011/01/18 2011/01/19 2011/01/20 2011/01/21 2011/01/22 2011/01/23 2011/01/24 2011/01/25 2011/01/26 2011/01/27 2011/01/28 2011/01/29 2011/01/30 2011/01/31
2011/02/01 2011/02/02 2011/02/03 2011/02/04 2011/02/05 2011/02/06 2011/02/07 2011/02/08 2011/02/09 2011/02/10 2011/02/11 2011/02/12 2011/02/13 2011/02/14 2011/02/15 2011/02/16 2011/02/17 2011/02/18 2011/02/19 2011/02/20 2011/02/21 2011/02/22 2011/02/23 2011/02/24 2011/02/25 2011/02/26 2011/02/27 2011/02/28
2011/03/01 2011/03/02 2011/03/03 2011/03/04 2011/03/05 2011/03/06 2011/03/07 2011/03/08 2011/03/09 2011/03/10 2011/03/11 2011/03/13 2011/03/14 2011/03/15 2011/03/16 2011/03/17 2011/03/18 2011/03/19 2011/03/20 2011/03/21 2011/03/22 2011/03/23 2011/03/24 2011/03/25 2011/03/26 2011/03/27 2011/03/28 2011/03/29 2011/03/30 2011/03/31
2011/04/01 2011/04/02 2011/04/03 2011/04/04 2011/04/05 2011/04/06 2011/04/07 2011/04/08 2011/04/09 2011/04/10 2011/04/11 2011/04/12 2011/04/13 2011/04/14 2011/04/15 2011/04/16 2011/04/17 2011/04/18 2011/04/19 2011/04/20 2011/04/21 2011/04/22 2011/04/23 2011/04/24 2011/04/25 2011/04/26 2011/04/27 2011/04/28 2011/04/29 2011/04/30
2011/05/01 2011/05/02 2011/05/03 2011/05/04 2011/05/05 2011/05/06 2011/05/07 2011/05/08 2011/05/09 2011/05/10 2011/05/11 2011/05/12 2011/05/13 2011/05/14 2011/05/15 2011/05/16

### Browse by creation date

66 72 73 75 79 85 86 87 88 89 90 91 92 93 96 97 00 01 02 03 04 05 06 07 08 09 10
1966/12
1972/02 1972/08
1973/04
1975/03
1979/08
1985/03 1985/05 1985/06
1986/05
1987/06
1988/01
1989/12
1990/01 1990/07 1990/08 1990/10
1991/05
1992/01 1992/06 1992/12
1993/10
1996/11
1997/12
2000/05 2000/06 2000/09 2000/11
2001/02 2001/03 2001/06 2001/07 2001/09 2001/10 2001/11
2002/01 2002/02 2002/03 2002/04 2002/07 2002/08 2002/09 2002/11
2003/01 2003/02 2003/03 2003/04 2003/05 2003/06 2003/07 2003/08 2003/09 2003/10 2003/11 2003/12
2004/01 2004/02 2004/03 2004/04 2004/05 2004/06 2004/07 2004/08 2004/09 2004/10 2004/11 2004/12
2005/01 2005/02 2005/03 2005/04 2005/05 2005/06 2005/07 2005/08 2005/09 2005/10 2005/11 2005/12
2006/01 2006/02 2006/03 2006/04 2006/05 2006/06 2006/07 2006/08 2006/09 2006/10 2006/11 2006/12
2007/01 2007/02 2007/03 2007/04 2007/05 2007/06 2007/07 2007/08 2007/09 2007/10 2007/11 2007/12
2008/01 2008/02 2008/03 2008/04 2008/05 2008/06 2008/07 2008/08 2008/09 2008/10 2008/11 2008/12
2009/01 2009/02 2009/03 2009/04 2009/05 2009/06 2009/07 2009/08 2009/09 2009/10 2009/11 2009/12
2010/01 2010/02

### Browse by origin

A B C D F G H I J K L M N O P Q R S T U V W Y Z
Embassy Athens Embassy Asuncion Embassy Astana Embassy Asmara Embassy Ashgabat Embassy Apia Embassy Ankara Embassy Amman Embassy Algiers Embassy Addis Ababa Embassy Accra Embassy Abuja Embassy Abu Dhabi Embassy Abidjan Consulate Auckland Consulate Amsterdam Consulate Adana American Institute Taiwan, Taipei
Embassy Bujumbura Embassy Buenos Aires Embassy Budapest Embassy Bucharest Embassy Brussels Embassy Bridgetown Embassy Bratislava Embassy Brasilia Embassy Bogota Embassy Bishkek Embassy Bern Embassy Berlin Embassy Belmopan Embassy Belgrade Embassy Beirut Embassy Beijing Embassy Banjul Embassy Bangkok Embassy Bandar Seri Begawan Embassy Bamako Embassy Baku Embassy Baghdad Consulate Barcelona
Embassy Copenhagen Embassy Conakry Embassy Colombo Embassy Chisinau Embassy Caracas Embassy Canberra Embassy Cairo Consulate Curacao Consulate Ciudad Juarez Consulate Chennai Consulate Casablanca Consulate Cape Town Consulate Calgary
Embassy Dushanbe Embassy Dublin Embassy Doha Embassy Djibouti Embassy Dili Embassy Dhaka Embassy Dar Es Salaam Embassy Damascus Embassy Dakar Consulate Dubai
Embassy Freetown Consulate Fukuoka
Embassy Guatemala Embassy Gaborone Consulate Guayaquil Consulate Guadalajara
Embassy Helsinki Embassy Harare Embassy Hanoi Consulate Ho Chi Minh City Consulate Hermosillo Consulate Hamilton Consulate Hamburg Consulate Halifax
Iran RPO Dubai Embassy Islamabad Consulate Istanbul
Embassy Jakarta Consulate Jerusalem Consulate Jeddah
Embassy Kyiv Embassy Kuwait Embassy Kuala Lumpur Embassy Kinshasa Embassy Kingston Embassy Kigali Embassy Khartoum Embassy Kathmandu Embassy Kampala Embassy Kabul Consulate Kolkata
Embassy Luxembourg Embassy Luanda Embassy London Embassy Ljubljana Embassy Lisbon Embassy Lima Embassy Lilongwe Embassy La Paz Consulate Lahore Consulate Lagos
Mission USOSCE Mission USNATO Mission UNESCO Embassy Muscat Embassy Moscow Embassy Montevideo Embassy Monrovia Embassy Minsk Embassy Mexico Embassy Mbabane Embassy Maputo Embassy Manila Embassy Manama Embassy Managua Embassy Malabo Embassy Madrid Consulate Munich Consulate Mumbai Consulate Montreal Consulate Monterrey Consulate Milan Consulate Melbourne
Embassy Nicosia Embassy Niamey Embassy New Delhi Embassy Ndjamena Embassy Nassau Embassy Nairobi Consulate Naples Consulate Naha
Embassy Ouagadougou Embassy Ottawa Embassy Oslo
Embassy Pristina Embassy Pretoria Embassy Prague Embassy Port Of Spain Embassy Port Louis Embassy Port Au Prince Embassy Phnom Penh Embassy Paris Embassy Paramaribo Embassy Panama Consulate Peshawar
Embassy Quito Consulate Quebec
REO Basrah Embassy Rome Embassy Riyadh Embassy Riga Embassy Reykjavik Embassy Rangoon Embassy Rabat Consulate Rio De Janeiro Consulate Recife
Secretary of State Embassy Suva Embassy Stockholm Embassy Sofia Embassy Skopje Embassy Singapore Embassy Seoul Embassy Sarajevo Embassy Santo Domingo Embassy Santiago Embassy Sanaa Embassy San Salvador Embassy San Jose Consulate Strasbourg Consulate St Petersburg Consulate Shenyang Consulate Shanghai Consulate Sapporo Consulate Sao Paulo
Embassy Tunis Embassy Tripoli Embassy Tokyo Embassy The Hague Embassy Tel Aviv Embassy Tehran Embassy Tegucigalpa Embassy Tbilisi Embassy Tashkent Embassy Tallinn Consulate Toronto Consulate Tijuana
USUN New York USEU Brussels US Office Almaty US Mission Geneva US Interests Section Havana US Delegation, Secretary UNVIE Embassy Ulaanbaatar
Embassy Vilnius Embassy Vienna Embassy Vatican Embassy Valletta Consulate Vladivostok Consulate Vancouver
Embassy Windhoek Embassy Wellington Embassy Warsaw
Embassy Yerevan Embassy Yaounde
Embassy Zagreb

### Browse by tag

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
AF AMGT ASEC AMED AEMR APER AORC AR ARF AG AS ABLD APCS AID AU APECO AFFAIRS AFIN ADANA AJ ADCO AA AECL AADP ACAO ANET AY APEC AORG ASEAN ABUD AGR AROC AO AE AM AODE AL ACABQ AGMT AX AMEX ATRN AFGHANISTAN AZ ASUP AND ARM AQ ATFN AMBASSADOR ACBAQ AFSI AFSN AGAO AC ADPM ASIG AUC ASEX AER AVERY AGRICULTURE ACOA ASCH AFU AINF AMG ASECKFRDCVISKIRFPHUMSMIGEG AORL ADM AN AIT AMCHAMS ALOW ACS
BR BA BK BD BU BEXP BO BM BT BRUSSELS BIDEN BTIO BE BY BB BL BG BP BC BBSR BH BX BF BWC BN BTIU BMGT BILAT
CA CASC CS CU CWC CBW CO CH CE CI CDG CVIS CG CM CICTE CMGT COUNTER CPAS COUNTRY CJAN CIDA CD CT CODEL CBE CW CDC CFED CONS CONDOLEEZZA CL COM CR CKGR CHR CVR CIA CLINTON CY COUNTERTERRORISM CITEL CLEARANCE COE CN CARICOM CB CACS CSW CIC CITT CACM CDB CF CJUS CTM CAN CLMT CBC CAC CNARC CV CROS CIS CBSA CEUDA CARSON CAPC COPUOS CTR
DR DA DK DHS DPRK DEPT DEA DJ DISENGAGEMENT DE DOMESTIC DOD DOE DTRA DS DEFENSE DO DAO DCM DEAX
EFIN ECON EAID ENRG EAIR EC ELAB ETRD EINV ETTC ECIN EPET EG EAGR EFIS EUN ECPS EU EN EIND ELTN EINT ECA EPA EWWT EMIN ENVI ENGR ETRC EXTERNAL EI ELN ETRDEINVECINPGOVCS ET EZ EK ES EINVEFIN ETRDECONWTOCS ER EUR ETC ENVR EAP ENIV ECONOMY EINN EFTA ECONOMIC EXBS ELECTIONS ECUN ENGY ECONOMICS EIAR EINDETRD ECONEFIN EURN EDU ETRDEINVTINTCS ECIP EFIM EAIDS EREL EINVETC ECONCS EUMEM ETRA ESA ECINECONCS EAIG ETRO EUREM EUC ENERG ERD EEPET EUNCH EXIM EFINECONCS ETRN ESENV ENNP EINVECONSENVCSJA ERNG
FI FR FTA FARC FJ FTAA FAC FBI FAO FAS FM FINR FREEDOM FOR FINANCE FOREIGN FOI FDA FMLN FO FISO
GV GG GM GH GOV GOI GL GT GF GR GCC GAERC GE GZ GA GAZA GY GLOBAL GTIP GERARD GANGS GTMO
HA HR HO HK HU HILLARY HI HURI HUMAN HYMPSK HSTC HEBRON HUMOR
IS IC IR IT IN IAEA IBRD ITU ILO IZ ID ICRC IPR ISRAELI IIP IMO INMARSAT IWC IV ITPGOV ITALIAN IO INTERNAL IRS ICTY IA INTERPOL IRAQI IEA INRB IL ICAO ICJ INR IMF ITALY IAHRC IZPREL IRAJ ITF IQ ILC IF ITPHUM ISRAEL IACI ICTR IEFIN INTELSAT INDO IDP IRC ITRA IBET INRA INRO IDA IGAD ISLAMISTS
JA JUS JO JOSEPH JM JP JAMES JOHN JOHNNIE
KCRM KNNP KDEM KFLO KTIP KFRD KWMN KJUS KSCA KSEP KFLU KOLY KHLS KCOR KTBT KPAL KISL KIRF KTFN KPRV KAWC KUNR KV KIPR KTIA KTDB KPAO KZ KBCT KN KPKO KSTH KSUM KIDE KS KU KWBG KPAONZ KOMC KNUC KMDR KE KNNPMNUC KSTC KWAC KERG KACT KFRDCVISCMGTCASCKOCIASECPHUMSMIGEG KSCI KGHG KHDP KVPR KICC KPRP KBIO KCIP KTLA KMPI KHIV KCSY KTRD KCFE KGIC KRVC KNAR KSPR KMRS KNPP KDRG KJUST KMCA KOCI KPWR KFIN KFSC KCMR KTER KRCM KIRC KSEO KNEI KCFC KSAF KSAC KR KG KCHG KAWK KGCC KPLS KREL KMFO KFTFN KTEX KCOM KO KLIG KDEMAF KBTR KRAD KGIT KVRP KPAI KICA KFRDKIRFCVISCMGTKOCIASECPHUMSMIGEG KHUM KREC KSEC KPIN KESS KDEV KWWMN KOM KBTS KCRS KWNM KRFD KVIR KMIG KDDG KRGY KMOC KIFR KID KAID KWMNCS KPOA KPAK KRIM KHSA KENV KOMS KWMM KNSD KX KCGC KCRCM KNUP
LE LY LI LH LTTE LG LO LAB LOG LT LABOR LU LA
MARR MNUC MX MOPS MO MCAP MASS MY MZ MTCRE MIL ML MPOS MP MG MD MK MA MI MOPPS MR MTS MLS MILI MAR MU MEPN MAPP MEPI MASC MEETINGS MERCOSUR MW MAS MTCR MT MCC MIK MARAD MAPS MV MILITARY MDC MEPP MEDIA MASSMNUC MUCN MC MTRE MRCRE MQADHAFI
NZ NU NP NO NATO NI NL NS NAFTA NDP NIPP NPT NE NZUS NH NR NA NSF NG NSG NC NEW NRR NATIONAL NT NASA NAR NV NSSP NK NATOPREL NPG NSFO NSC NORAD NW NGO NPA
OTRA OVIP OPCW OPDC OREP OAS OPIC OECD OFDP OPRC OIIP OEXC ODIP OSCE OIE OSCI OTR OMIG OSAC OBSP OFDA OFFICIALS OVP OIC OHUM ON OCII OES OPAD OCS
PGOV PREL PRAM PTER PREF PARM PHUM PINR PA PE PM PK PINS PMIL PROP PALESTINIAN PBTS PARMS PHSA POL PO PROG POLITICS PBIO PL PTERE PRGOV PORG PP PS PGOF PKFK PSOE PEPR PPA PINT PMAR PRELP PREFA PINF PNG POLICY PFOR PUNE PGOVLO PAO PHUMBA PSEPC PNAT PNR POLINT PGOVE PHALANAGE PARTY PDEM PECON PROV PBT PAK PGOC PY PLN PGIV PHUH PF PRL PG PHUS PTBS PU POV POLITICAL PARTIES PCUL PGGV PSA PGOVSMIGKCRMKWMNPHUMCVISKFRDCA PINL PAS PDOV PHUMPGOV POGOV PREO PEL PHUMPREL PCI PAHO PSI PAIGH POSTS
QA
RO RU RS RP RW RICE RM RSP RF RCMP RIGHTS RIGHTSPOLMIL RUPREL RELATIONS REACTION RFE ROOD REGION REPORT RSO ROBERT
SENV SMIG SNAR SOCI SP SY SYRIA SZ SU SA SCUL SW SO SL SR SENVKGHG SF SI SEVN SARS SN SC SAN STEINBERG SG ST SIPDIS SNARIZ SNARN SSA SK SPCVIS SOFA SYR SANC SWE SHI SEN SHUM SH SPCE SNARCS SIPRS SAARC SCRS
TSPL TF TU TRGY TS TBIO TT TK TPHY TI TSPA TERRORISM TH TIP TC TNGD TW TX TO TRSY TN TURKEY TL TV TD TZ TBID TINT TP TFIN TAGS TR THPY
UK UNGA UN UNCHC UNSC UV US UY USTR UNHRC UP UG USUN UNESCO USPS UZ USEU UNCHR USAID UNMIK UNHCR UE UNVIE UAE UNO UNDP UNAUS USOAS UNODC UNCHS UNFICYP UNEP UNIDROIT UNDESCO UNC UNPUOS UNCSD UNDC UNICEF USNC UNCND
VE VT VZ VTPREL VM VTIZ VAT VN VC VI VTEG
WTO WTRO WS WI WZ WHO WBG WB WWARD WHA WITH WIPO WTRQ WEU WMO WA WHTI WFP WMD
XF XM XG XT XZ XA XY XK XL XW XV XB XU XS XR XH XD XC XX XE XQ XTAG XI
YM YI YE YMCS
ZI ZU ZR ZB ZJ ZP ZEALAND ZN ZL ZA ZK ZF ZANU ZO ZOELLICK

### Browse by classification

CONFIDENTIAL CONFIDENTIAL//NOFORN SECRET SECRET//NOFORN UNCLASSIFIED UNCLASSIFIED//FOR OFFICIAL USE ONLY

### Community resources

Follow us on Twitter Check our Reddit Twitter this Digg this page Contact us on IRC

courage is contagious

### Viewing cable 08HELSINKI311, FINNISH GOVERNMENT APPROVES PHARMACEUTICAL

If you are new to these pages, please read an introduction on the structure of a cable as well as how to discuss them with others. See also the FAQs
Understanding cables
Every cable message consists of three parts:

- The top box shows each cables unique reference number, when and by whom it originally was sent, and what its initial classification was.
- The middle box contains the header information that is associated with the cable. It includes information about the receiver(s) as well as a general subject.
- The bottom box presents the body of the cable. The opening can contain a more specific subject, references to other cables (browse by origin to find them) or additional comment. This is followed by the main contents of the cable: a summary, a collection of specific topics and a comment section.

To understand the justification used for the classification of each cable, please use this WikiSource article as reference.
Discussing cables
If you find meaningful or important information in a cable, please link directly to its unique reference number. Linking to a specific paragraph in the body of a cable is also possible by copying the appropriate link (to be found at theparagraph symbol). Please mark messages for social networking services like Twitter with the hash tags #cablegate and a hash containing the reference ID e.g. #08HELSINKI311.

Reference ID | Created | Released | Classification | Origin
--- | --- | --- | --- | ---
08HELSINKI311 | 2008-07-09 09:35 | 2011-04-24 00:00 | UNCLASSIFIED | Embassy Helsinki

`

    VZCZCXYZ0002
    RR RUEHWEB

    DE RUEHHE #0311/01 1910935
    ZNR UUUUU ZZH
    R 090935Z JUL 08
    FM AMEMBASSY HELSINKI
    TO RUEHC/SECSTATE WASHDC 4415
    RUCPDOC/DEPT OF COMMERCE WASHDC
    INFO RUCNMEU/EU INTEREST COLLECTIVE
    RUEHNY/AMEMBASSY OSLO 4744

` `

    UNCLAS HELSINKI 000311

    SIPDIS

    E.O. 12958: N/A
    TAGS: ETRD FI PREL
    SUBJECT: FINNISH GOVERNMENT APPROVES PHARMACEUTICAL

    REFERENCE PRICING SYSTEM

    ¶1. Summary:  In a disappointing move and despite Embassy and
    industry efforts, the Finnish cabinet voted unanimously June
    25 to approve a reference pricing scheme for pharmaceuticals,
    a provision of which undermines the value of patent
    protection for medicines created and manufactured by U.S. and
    other pharmaceutical companies. Parliament is expected to
    approve the proposal at the end of the summer.  Despite the
    fact that the Ministry of Economy and Employment, the
    Ministry of Foreign Affairs and the Chancellor of Justice
    initially opposed the proposal and Prime Minister Vanhanen
    was equivocal, in the end all acquiesced and supported the
    Minister of Social Affairs and Health and the short-term
    attraction of an estimated 50 million euros annually in
    savings.  Embassy will engage key parliamentary figures in
    the next month to urge that the government develop a revised
    proposal that achieves their stated objective of containing
    health care costs but that will maintain the level of
    intellectual property protection that pharmaceutical
    companies have previously enjoyed in Finland and continue to
    enjoy elsewhere in the European Union.  If the proposal
    passes as written, post will consult with local U.S. industry
    and Washington to determine if a Special 301 listing is
    appropriate in the 2009 cycle.  End Summary.

    ----------
    Background
    ----------

    ¶2.  Product patents have been granted in Finland only since
    ¶1995.  As such, nearly all products on the Finnish market are
    still protected only by analoguous process patents.  Prior to
    2006, when Finland enacted the fix it is now proposing to
    withdraw, the level of protection for innovative medicines in
    Finland was among the lowest in the EU.  At that time,
    industry faced three major hurdles that taken together formed
    a perfect storm:  weak patent protection, liberal market
    authorization and mandatory generic substitution.

    --------------------------------------------- -------
    Finland Does the Right Thing But Then Changes Course
    --------------------------------------------- -------

    ¶3.  After much Industry and Embassy lobbying, in 2006, the
    Finnish government established criteria in Section 57(c) of
    its Medicines Act that excluded pharmaceutical products from
    generic reimbursement if they were protected by an analogus
    process patent in Finland and enjoyed valid patent protection
    in at least five other countries in the European Union.
    57(c) was the result of long negotiations and was seen by
    industry as a fair and equitable solution.  Indeed, it was
    used as an example for other countries, notably Norway, of
    the ideal legislative remedy.  Trouble started in the summer
    of 2007 when the Finnish Pharmaceutical Pricing Board (PPB)
    began cancelling the reimbursement status of some innovative
    drugs, claiming the PPB was bound only by the Health
    Insurance Act, not the the Medicines Act that contained the
    exclusion criteria. At first, Industry and Econoff believed
    this was an isolated action by an overzealous PPB chief,
    especially because when we raised it with the newly-installed
    Health Minister, she freely admitted she did not know what we
    were talking about.  Clearly she eventually got up to speed,
    because before long her ministry was overtly supporting the
    complete withdrawal of the 57(c) arrangement instead of
    supporting similar exclusion criteria for the Health
    Insurance Act as industry was proposing.

    ------------------------
    USG and Industry Efforts
    ------------------------

    ¶4. Beginning late last year, Econoff and Commercial Officer
    began working closely with the U.S. pharmaceutical company
    representatives here in Finland as well as with the local
    trade association Pharma Industry Finland (PIF) and its
    director, former Finance Minister Suvi-Anne Siimes to devise
    a strategy to head off the cancellation of 57(c).  Since
    January 2008 the Embassy has raised this at the highest level
    of Finnish government, including with the Prime Minister but
    also with virtually every other minister in the entire
    government.  Our strategy, carefully coordinated with
    industry and Washington, has focused on underscoring that
    Finland's knowledge-based economy has attracted much r&d
    investment, including health-related project funds from the
    USG.  A small IPR deficiency would undermine Finland's
    deserved reputation for innovation, a blow that was surely
    not worth the short-term gains from savings.  Industry
    reinforced this message during the visit of Alex Azar, Eli
    Lilly's Senior VP for Corporate Affairs (and a former Deputy
    Secretary of HHS) and through intensive lobbying by PIF and
    Siimes.  Siimes has also reached out to the German, French

    and Swiss Embassies whose companies also stand to suffer
    under the new arrangement.  USTR Ambassador Schwab and
    Secretary Gutierrez have written their Finnish counterparts
    on this issue and it has been raised with the Finnish Embassy
    in Washington and during the visits of high-level Finnish
    government officials.

    ----------
    Next Steps
    ----------

    ¶5.  With the cabinet's approval of the reference pricing
    scheme and the subsequent removal of the protection
    innovative products enjoyed under Section 57(c), there are
    few steps left.  Nonetheless, Embassy has a small window
    until the end of the summer when parliament will reconvene
    and consider the proposal.  Given that the MPs' party
    representatives in the cabinet have already approved the
    proposal, however, chances for success are slim.  However, we
    remain committed to raising this with parliamentary leaders
    in an attempt to encourage the development of a revised
    proposal.  If that fails, we will examine whether this
    unfortunate set of events merits Finland's inclusion on the
    Special 301 list.

    BUTLER

`